Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/17/2003EP1343507A2 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343502A2 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
09/17/2003EP1343501A1 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers
09/17/2003EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
09/17/2003EP1343485A2 Lipid-based nitric oxide donors
09/17/2003EP1343476A2 Preparation of large liposomes by infusion into peg
09/17/2003EP1343372A2 Pulmonary delivery of polyene antifungal agents
09/17/2003EP1343370A2 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
09/17/2003EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
09/17/2003EP1282084B1 Method for preparing pyrimidone derivatives with antifungal activity
09/17/2003EP1230260B1 Hcv ns3 protease inhibitors
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1181300B1 6-o-carbamate ketolide derivatives
09/17/2003EP1143966B1 Preparation for warts
09/17/2003EP1091763B1 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters
09/17/2003EP1058548B1 The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease
09/17/2003EP1030852B1 Oxazolidinone derivatives and pharmaceutical compositions
09/17/2003EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof
09/17/2003EP1001798B1 Method for preventing or treating a human immunodeficiency virus infection
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003EP0842428B1 Process for producing gm2 specific antibodies
09/17/2003EP0831937B1 Immunological combination compositions and methods
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof
09/17/2003CN1443197A Acid-modified arabinogalactan protein composition
09/17/2003CN1443191A Methods and compositions for treating hepatitis c virus
09/17/2003CN1443189A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443158A Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
09/17/2003CN1443150A Noval antibiotic compounds
09/17/2003CN1443076A Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine
09/17/2003CN1443075A Compositions and methods for treatment of candidiasis
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/17/2003CN1442430A AsLc-IFN fusion protein and its preparation
09/17/2003CN1442203A SARS crown virus and AIDS virus (HIV-1)-CD 147 acceptor target antagonist
09/17/2003CN1442200A Medicine for preventing and treating AIDS
09/17/2003CN1442181A Medicine for treating chronic hepatitis
09/17/2003CN1442172A External use medicine for treating blister sore
09/17/2003CN1442163A Chinese medicine formula for treating livestock foot and mouth disease
09/17/2003CN1442157A Medicine for treating rheumatic and rheumatoid disease and its preparation method
09/17/2003CN1442155A Lulusu synthetic medicinal liquid
09/17/2003CN1442151A Mackefulan immune liquid
09/17/2003CN1442144A Antibacterial composite medicine
09/17/2003CN1442143A Antibacterial composite medicine
09/17/2003CN1442142A Antibacterial composite medicine
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1442138A Fukangzuo injection fluid and its preparation method
09/17/2003CN1442136A Application of porcelain ampelopsis in preparation of medicine for preventing and treating AIDS
09/17/2003CN1121404C Antifungal agent and its preparing process and intermediate
09/17/2003CN1121234C Antiphlogistic cough relieving medicine
09/17/2003CN1121232C Pharmaceutical composition for treatment of herpes
09/17/2003CN1121227C Veterinary medicine prepared from sophora seed and its preparing process
09/17/2003CN1121217C Immunological compound
09/17/2003CN1121216C Veterinary use of pleuromutilin derivative
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620911 Dolastatin 10 derivatives, of given formula; administering to infected human; useful as fungicides
09/16/2003US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen
09/16/2003US6620841 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS)
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620810 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
09/16/2003US6620435 Compositions for topical application of therapeutic agents
09/16/2003US6620412 Prophylactic and therapeutic monoclonal antibodies
09/16/2003US6620379 Apparatus and method of treatment of wounds, burns and immune system disorders
09/16/2003CA2283671C Salt of naphthyridine carboxylic acid derivative
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2167408C Process for making hiv protease inhibitors
09/16/2003CA2099898C Antibacterial antiplaque oral composition
09/16/2003CA2054590C Novel cyclosporins
09/16/2003CA2025490C Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
09/12/2003WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003WO2003074682A1 Bacterial spores
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074570A1 Novel branched sialo-sugar molecules and antiviral agents using the same
09/12/2003WO2003074569A2 Bispecific antibody point mutations for enhancing rate of clearance
09/12/2003WO2003074547A2 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
09/12/2003WO2003074524A2 Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
09/12/2003WO2003074512A1 Isoquinoline derivatives
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003074057A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073989A2 Nucleoside 5'-monophosphate mimics and their prodrugs
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use
09/12/2003WO2003061558A3 Glycoconjugate vaccines for use in immune-compromised populations
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003048371A3 Dna vaccine
09/12/2003WO2003047524A3 Methods and compositions for modulating the immune system and uses thereof
09/12/2003WO2003039559B1 Pharmaceutical combinatons comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
1 ... 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 ... 1798